MedTrace Logo

Pharmacokinetics of Oral Antiplatelet Agents After Distal Gastrectomy

NCT05543863 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2022-09-21

No results posted yet for this study

Summary

This study is aimed to investigate the changes in pharmacokinetics and efficacy of antiplatelet agents before and after distal gastrectomy in gastric cancer patients taking oral antiplatelet agents for primary or secondary treatment for cardiovascular disease and to evaluate its impact on the occurrence of postoperative bleeding complications and thromboembolic events.

Conditions

Interventions

DIAGNOSTIC_TEST

Platelet function testing

platelet function testing (Platelet function analyzer-100 (PFA-100) collagen epinephrine closure time, VerifyNowⓇ Assays (aspirin, P2Y12)) before surgery and 5 days, 3 months after surgery

Sponsors & Collaborators

  • Kyungpook National University Chilgok Hospital

    lead OTHER

Principal Investigators

  • Ji Yeon Park, MD · Dept. of Surgery, Kyungpook National Univ. Chilgok Hosptal

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-20
Primary Completion
2023-03-31
Completion
2023-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05543863 on ClinicalTrials.gov